Clinical Trial Update: Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating pomalidomide and dexamethasone with or without ixazomib for relapsed multiple myeloma across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)
• ixazomib (ixazomib)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Multiple Myeloma in Relapse | Phase 1, Phase 2 | Status: UNKNOWN | Results posted: 2023-12-01